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Abstract
Apoptosis is of pivotal importance in the pathogenesis of sepsis.
Depending on the cell type involved and the time point of the
disease process, apoptosis may be linked to either a good or a bad
outcome. Work presented in this issue by Giamarellos-Bourboulis
and coworkers suggests that an early increase in the apoptosis of
blood monocytes is associated with improved survival in patients
with varying degrees of sepsis. Although the mechanism by which
monocyte apoptosis influences the outcome of sepsis cannot be
determined by this study, these observations represent an
important advance in our understanding of this complicated
disease process.
Apoptosis is a tightly regulated process by which cells
orchestrate their own dismantling and disposal in an orderly
and noninflammatory manner. Apoptosis is critical for
homeostasis, development and – as highlighted by recent
work from Giamarellos-Bourboulis and colleagues [1]
(presented in this issue) – for regulation of inflammation and
immune cell function. Since its first description in 1972 [2]
there has been an explosion of literature on this topic. A
Pubmed search for ‘apoptosis’ yields over 100,000 citations.
A question when faced with such a number is coincidentally
the same as that raised by Giamarellos-Bourboulis and
colleagues; when is enough apoptosis, enough?
Sepsis and septic shock represent an over-exuberant host
response to an infectious insult. Neutrophils, monocytes and
tissue macrophages play key roles in the initial reaction and
release a variety of cytokines to marshal the immune
response. Once the threat is contained and/or the adaptive
immune response is awakened, the innate immune cells are
downregulated and must be disposed of in a timely and
noninjurious manner because some of them are proverbial
‘ticking time bombs’. Apoptosis represents a key mechanism
in this orderly downregulation and disposal.
It has been suggested that dysregulated apoptosis may play
a role in increasing the duration and/or severity of the
systemic response to sepsis [3]. Clearly, monocytes and
macrophages can contribute to inflammation simply by
‘hanging around’ longer with the opportunity to release their
cytotoxic products that damage host cells. Additionally, there
is evidence that phagocytosis of apoptotic cells leads to
active elaboration of anti-inflammatory signals [4]. Thus,
reduced apoptosis may contribute to inflammation in a
number of ways, with the end result being that the host
immune response contributes more to damaging the host
than to protecting it. However, apoptosis is not all good. It is
important to note that apoptosis of structural cells such as
endothelium or epithelium in systemic inflammatory response
syndrome is associated with disrupted organ function [5,6].
Furthermore, lymphocyte apoptosis is associated with a poor
outcome in septic shock [7], presumably because these cells
are important regulators of the immune response and
coordinate the body’s response to infection.
Giamarellos-Bourboulis and coworkers [1] add to this
literature and present evidence that early monocyte apoptosis
confers a survival advantage in sepsis related to ventilator-
associated pneumonia. Their study group of patients was
divided into those with low (<50%) and high (>50%) rates
of monocyte apoptosis when tested on day 1. Forty-nine per
cent (28 out of 57) of those with low apoptosis died versus
only 15% (5 out of 33) of those with high degrees of mono-
cyte apoptosis. This is a remarkable finding, and theirs is one
of the first studies to correlate monocyte apoptosis with
survival in sepsis. However, some questions arise from these
observations.
First, is monocyte apoptosis in the study simply a marker for
another more proximate factor that is causally associated with
mortality? The authors note that there is a difference in the
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incidence of bacteraemia between the low and high
apoptosis groups but they do not discuss any other
parameters. Although this group of 90 patients is as
homogenous as one can except in a study of sepsis, there
are differences between patients that could contribute to
mortality. Thus, demographic factors (age, sex), illness
severity (Acute Physiology and Chronic Health Evaluation II
score, Sequential Organ Failure Assessment score) and
other comorbid conditions (trauma, diabetes, medications,
etc.) may be confounding variables if differences exist
between the low and high apoptosis groups.
Second, percentage apoptosis changed over the 7 days
during which blood was collected, and so those patients
assigned to the low group may at times have had more than
50% apoptosis and vice versa. What is the significance of
this? Timing of apoptosis is sure to be important
(theoretically, too much too early may be associated with a
poor outcome, as would too little too late). Duration of illness
before enrolment in this study may introduce enough
variability to make timing difficult to determine.
Third, if monocyte apoptosis is beneficial, then what is the
mechanism? One possibility, mentioned by the authors, is a
decreased release of proinflammatory cytokines by
monocytes undergoing apoptosis. However, of the serum
cytokines measured (intereukin-6, interleukin-8 and tumour
necrosis factor-α) no correlation with survival was noted. This
is a critical issue if we hope to modulate this process to the
advantage of patients.
Finally, there are a variety of technical considerations in
measuring apoptosis in peripheral blood monoctyes that
introduce uncertainty into the measurement. Discarded
nonadherent cells may have been apoptotic monocytes. The
recovery of apoptotic monocytes may not be complete in a
Ficoll density gradient because cell density is altered by
apoptosis. Also, healthy monocytes may ingest apoptotic
cells and through membrane transfer subsequently stain
falsely positive for annexin V. Ultimately, it may be the
responses of monocytes that have already extravasated from
the blood into the tissues that is most relevant to the outcome
of sepsis, and this was not measured in the study.
Given these points, it is too soon to say with certainty that
increased early monocyte apoptosis confers a survival
advantage in the context of sepsis. However, the study by
Giamarellos-Bourboulis and coworkers is an important first
step in trying to make sense of a complicated and
fundamentally important process. At the very least, this assay
of monocyte apoptosis may conceivably be used as a
prognostic tool, especially if it is combined with other factors
in a multivariate model.
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